Retatrutide is an investigational single molecule that activates the body's receptors for three hormones - glucagon, glucose-dependent insulinotropic polypeptide (GIP), and glucagon-like peptide-1 (GLP-1), and is being studied for the treatment of obesity.
Product Name | Retatrutide |
CAS NO. | 2381089-83-2 |
Other name | LY3437943 GIPR/GLP-1R |
Appearance | White freeze dry Powder |
Purity | 99.88%min. HPLC |
Application | Drug peptides |
Shelf Life | 24Months |
Storage | Store at a temperature of 2-8 oC, protected from light |
How is Retatrutide different from Semaglutide and Trizepatide ?
Mechanism:
1. Semaglutide work as (GLP-1) hormone agonist.
2. Tirezepatide work as (GLP-1 & GIP ) hormone agonist.
3. Retatrutide work as (GLP-1 & GIP & Glucagon) hormones agonist.
Weight loss in trials:
1. Semaglutide led to a 6-12% reduction in body weight in 28 weeks
2. Tirezepatide led to a 15-20% reduction in body weight in 72 weeks
3. Retatrutide led to a 25% reduction in body weight in 48 weeks